Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yoshinori Hiroshima"'
Autor:
Norio Mitsuhashi, Hajime Ikeda, Yoshitaka Nemoto, Mayumi Kuronuma, Masahiro Kamiga, Yoshinori Hiroshima
Publikováno v:
Palliative Medicine Reports, Vol 2, Iss 1, Pp 355-364 (2021)
Purpose: To report the hemostatic effects of palliative radiation therapy (RT) for the prevention of blood transfusions (BT) in patients with advanced gastric cancer (AGC). Methods and Materials: Twenty-eight patients who received palliative three-di
Externí odkaz:
https://doaj.org/article/2533d8d344f143f8a80e12a31f276cd7
Publikováno v:
Progress of Digestive Endoscopy. 98:107-109
Autor:
Norihito Hida, Yoshinori Hiroshima, Nobuyuki Hizawa, Takefumi Saito, Shinichi Yoshii, Hideyasu Yamada, Hiroaki Satoh, Tetsuya Yamagishi
Publikováno v:
Anti-Cancer Drugs. 30:105-109
Lung cancer is a major health concern worldwide, but new immunotherapeutic treatments for lung cancer have shown great promise and the prognosis for many severe cancers including lung cancer has been improving. In May 2017, the Food and Drug Administ
Autor:
Yoshinori Hiroshima, Daisuke Suganuma
Publikováno v:
Progress of Digestive Endoscopy. 98:64-65
Autor:
Toshiaki Narasaka, Mariko Wakayama, Mitsuaki Hirose, Daisuke Akutsu, Takashi Mamiya, Katsumasa Kobayashi, Yoshinori Hiroshima, Yuji Mizokami, Kenji Matsuda, Takahisa Watahiki, Hiroyasu Ishida, Kazuto Ikezawa, Ichinosuke Hyodo, Shinji Endo
Publikováno v:
Gastrointestinal Endoscopy. 88:370-377
Background and Aims We previously reported preliminary safety results for a new method, endoscopic detachable snare ligation (EDSL), for diverticular hemorrhage. This method does not need endoscope removal to attach a ligation device after detection
Autor:
Shinji Endo, T. Nishina, T. Matsumoto, Hirosumi Suzuki, Kazunori Ishige, Ichinosuke Hyodo, Toshikazu Moriwaki, Sachiko Hirai, Kenji Matsuda, T. Kajiwara, Yoshinori Hiroshima, Takeshi Yamada, Mariko Kobayashi, Akinori Sugaya, Yoshiyuki Yamamoto
Publikováno v:
Diseases of the Esophagus. 27:737-743
The survival benefit of second-line chemotherapy with docetaxel in platinum-refractory patients with advanced esophageal cancer (AEC) remains unclear. A retrospective analysis of AEC patients with Eastern Cooperative Oncology Group performance status
Autor:
Takunori Ueno, Naoyuki Hasegawa, Mitsuaki Hirose, Toshiaki Narasaka, Yoshiyuki Yamamoto, Daisuke Ochi, Yoshinori Hiroshima, Ichinosuke Hyodo, Tsuyoshi Kaneko, Toshikazu Moriwaki, Hideo Suzuki, Takeshi Yamada, Kuniaki Fukuda, Shinji Endo, Rie Saito, Yuji Mizokami
Publikováno v:
Internal Medicine. 53:1055-1062
Adenocarcinomas arising from the ectopic pancreas in the gastrointestinal wall are rarely described in the literature. In addition, obtaining an accurate preoperative diagnosis is difficult in most cases because these adenocarcinomas occur primarily
Autor:
Jun Higashijima, Takashi Maeba, Tomohiro Nishina, Toshikazu Moriwaki, Tadamichi Denda, Yuji Yamamoto, Minoru Mizuta, Toshiki Masuishi, Kenji Amagai, Ikuo Takahashi, Go Nakajima, Yoshinori Hiroshima, Shunju Indo, Mitsuharu Ozeki, Yoshinori Sakai, Hiroyasu Ishida, Mikio Sato, Mitsuo Shimada, Yuji Negoro, Ichinosuke Hyodo
Publikováno v:
Clinical colorectal cancer. 15(3)
Background We previously reported that uracil-tegafur with oral leucovorin (UFT/LV) treatment for elderly patients (aged ≥ 75 years) was well-tolerated in a phase II study. In the present study, the efficacy and safety of a modified (1-week shorter
Autor:
Yuichi Dai, Hiroaki Sugiyama, Sayoko Shidara, Takashi Mamiya, Kazuto Ikezawa, Akira Nakahara, Atsuko Soeda, Yoshinori Hiroshima
Publikováno v:
Clinical journal of gastroenterology. 7(5)
Collagenous gastritis (CG) is a rare disorder characterized by the thick collagenous subepithelial bands associated with mucosal inflammation. There have been approximately fifty reports in the literature since it was first described in 1989. Accordi
Autor:
Tadamichi Denda, Minoru Mizuta, Ikuo Takahashi, Tomohiro Nishina, Mitsuo Shimada, Jun Higashijima, Go Nakajima, Takashi Maeba, Yoshinori Sakai, Toshikazu Moriwaki, Toshiki Masuishi, Ichinosuke Hyodo, Masamitsu Morimoto, Mitsuharu Ozeki, Yoshinori Hiroshima, Yuji Negoro, Mikio Sato, Shunju Indou, Hiroyasu Ishida
Publikováno v:
Journal of Clinical Oncology. 32:588-588
588 Background: Now fluoropyrimidine plus Bmab is considered a recommendable option to the majority of elderly mCRC patients who are deemed inappropriate for the standard doublet chemotherapy with biologics. Our previous phase II study of UFT/ LV in